EC Paediatrics

Below is a clinical case of severe generalized tetanus in a 10-year-old patient who did not receive vaccination. The objective of this case report is to provide scientific evidence that allows to generate awareness about the importance of vaccination for the prevention of Clostridium tetani infection. Case presentation: 10-year-old woman admitted to the Pediatric Intensive Care Unit (PICU) transferred from a second-level hospital; with a history of a penetrating lesion by wood splinter on the right foot, arriving 2 weeks after the injury and the presentation of the following symptoms prior to transfer to the Hospital for the Poblano Child: trismos, stiffness in the neck, trunk and extremities. Upon admission to our PICU patient in phase III of ventilation and under sedation, however, presented evident opisthotones. During their stay, lack of vaccination is identified, the clinical diagnosis is made and the treatment was multidisciplinary which included Infectology, Neurology, Rehabilitation and Nutrition. Patient with favorable evolution and leaves in good conditions with follow-up appointment to Neurology and Rehabilitation. Conclusions: vaccination is important for the prevention of tetanus; and multidisciplinary management brings good results.

Keywords: Generalized Tetanus; Vaccination; Case Report

1. Cobertura vacunal (2021).
2. Yen LM and Thwaites CL. “Tetanus”. The Lancet 393 (2019): 1657-1668.
3. Bogusz J., et al. “Tetanus in Poland in 2018-2019”. Przeglad Epidemiologiczny3 (2021): 361-366.
4. Secretaria de Salud. Notificación semanal de casos nuevos de enfermedades (2021).
5. Haschek WM., et al. “Nervous System”. In: Fundamentals of Toxicologic Pathology. Elsevier (2010): 377-410.
6. Berkowitz AL. “Tetanus, Botulism, and Diphtheria” (2018).
7. Ataro P., et al. “Tetanus: A review”. Southern Medical Journal 104 (2011): 613-617.
8. Tiwari TSP. “Tetanus”. In: International Encyclopedia of Public Health. Elsevier Inc (2016): 158-163.
9. Manuel J and Aranda R. “Resurgimiento de enfermedades infecciosas y movimiento antivacunas, ¿qué pasa en México?” Atención Familiar 4 (2020): 208-221.
10. Almas T., et al. “The Spectrum of Clinical Characteristics and Complications of Tetanus: A Retrospective Cross-Sectional Study From a Developing Nation”. Cureus (2021).
11. Govender I and Clark C. “Tetanus: a patient in a primary healthcare setting”. Southern African Journal of Infectious Diseases3 (2015): 85-88.
12. Olum S., et al. “Tetanus in a rural low-income intensive care unit setting”. Brain Communications1 (2021).
13. Tetanus: For Clinicians | CDC (2021).
14. Olum S., et al. “Tetanus in a rural low-income intensive care unit setting”. Brain Communications1 (2021).
15. Nepal G., et al. “Safety and efficacy of Magnesium Sulfate in the management of Tetanus: A systematic review”. Tropical Medicine and International Health 10 (2021): 1200-1209.
16. Talukdar AM., et al. “The novel early use of dexmedetomidine in the management of tetanus”. Journal of Clinical Anesthesia 50 (2018): 18-19.
17. Boyarchuk O., et al. “A report of five child tetanus cases”. Journal of Pediatric Infectious Diseases4 (2020): 200-205.
18. Centro Nacional para la Salud de la Infancia y Adolescencia. Manual de Vacunación. Secretaría de Salud (2022).